Evidence map›Paper›PMID 39523328›Full record

ArticleBMC medicine2024

Association between within-target risk factors and life expectancy free from cardiovascular disease, cancer, and dementia in individuals with type 2 diabetes in New Zealand between 1994 and 2018: a multi-ethnic cohort study.

Dahai Yu, Zhanzheng Zhao, Karen Pickering, John Baker, Richard Cutfield, Brandon J Orr-Walker, Gerhard Sundborn, Zheng Wang, Yamei Cai, Hang Fu and 2 more

Abstract read
In one paragraph

Article in BMC medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Dahai YuHenan Key Laboratory of Chronic Disease Prevention and Therapy & Intelligent Health Management, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, China. d.yu@keele.ac.uk.
Zhanzheng ZhaoDepartment of Nephrology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, China.
Karen PickeringDiabetes Foundation Aotearoa, Otara, New Zealand.
John BakerDiabetes Foundation Aotearoa, Otara, New Zealand.
Richard CutfieldDiabetes Foundation Aotearoa, Otara, New Zealand.
Brandon J Orr-WalkerDiabetes Foundation Aotearoa, Otara, New Zealand.
Gerhard SundbornSection of Pacific Health, The University of Auckland, Auckland, New Zealand.
Zheng WangDepartment of Nephrology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, China.
Yamei CaiDepartment of Nephrology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, China.
Hang FuHenan Key Laboratory of Chronic Disease Prevention and Therapy & Intelligent Health Management, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, China.
Chengzeng WangHenan Key Laboratory of Chronic Disease Prevention and Therapy & Intelligent Health Management, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, China. czw202112@zzu.edu.cn.
David SimmonsDepartment of Nephrology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, China. Da.Simmons@westernsydney.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe extent to which type 2 diabetes (T2D) reduces life expectancy depends on the risk of complications. We aimed to characterise the relationship between risk factors for diabetes complications and life expectancy, in individuals with T2D, free from major chronic disease, in a regional database linked with national New Zealand health databases.

methodsA prospective cohort study design was employed, analysing data from individuals with T2D drawn from the comprehensive Diabetes Care Support Service database (1994-2018). Participants with known values for all five within-target risk factors (WTRF +) including blood pressure, glycaemia, and LDL cholesterol, alongside being non-smoking with normal renal function at baseline, were included. Life expectancy free from cardiovascular disease (CVD), cancer, and dementia at age 50 years was estimated using multistate life tables, adjusting for demographics and clinical metrics.

resultsWomen and men with no WTRF + at enrolment had a life expectancy free from CVD, cancer, or dementia of 13.1 (95% confidence interval: 9.1-19.0) and 11.2 (6.7-18.6) years, respectively. For the most socioeconomically deprived groups or Māori with no WTRF + at baseline, life expectancies were markedly lower. Life expectancies were 23.7 (18.9-29.7) years for women and 23.2 years (17.2-31.4) years for men with four or five WTRF + at baseline, respectively. While an increasing number of WTRF + at baseline was significantly associated with improved outcomes in men and certain subgroups (e.g. Other ethnicity group), this trend was not statistically significant for women overall or in most subgroups.

conclusionsHaving multiple WTRF + at baseline is associated with a considerable increase in life expectancy free from major chronic disease among individuals with T2D. This highlights the importance of lifestyle and clinical interventions in the management of T2D and in the prevention and management of associated chronic conditions.

Indexed as

Cardiovascular DiseasesDementiaDiabetes Mellitus, Type 2Life ExpectancyNeoplasmsAgedCohort StudiesEthnicityFemaleHumansMaleMiddle AgedNew ZealandProspective StudiesRisk FactorsCancerCardiovascular diseaseDementiaEthnic disparityHealthy life expectancyLife expectancyMāoriNew ZealandSocioeconomic inequalityType 2 diabetes

Identifiers

PMID39523328
PMCPMC11552122

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.